Toshi Menju

18PUBLICATIONS
89CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Powder and particle technologyMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 06, 2026
Preoperative sarcopenia diagnosed based on the asian working group criteria and Short-term outcomes in older patients undergoing resection of early-stage non-small cell lung cancer.

|Jul 01, 2026
Impact of Pathological Lymphovascular Invasion of Lung Adenocarcinoma after Induction Chemoradiotherapy.

|May 25, 2026
Development of a model to predict high-risk histopathological features in early T-stage lung adenocarcinoma using thin-slice CT and FDG-PET/CT parameters for selecting optimal candidates for sub-lobar resection.

|Feb 09, 2026
Evaluation of Radiofrequency Identification for Accurate Wedge Resection of Small Lung Lesions With Reference to Dye Marking.

Taiki Ryo, Yojiro Yutaka, Yu Hidaka

|Dec 10, 2025
Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells.

Takahiro Tsuji, Haruka Hirose, Daisuke Sugiyama

|Jan 27, 2025
ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 Inversely Regulates Programmed Death-Ligand 1 Through Negative Feedback of Phosphorylated Epithelial Growth Factor Receptor and Activation of Nuclear Factor-Kappa B in Non-Small Cell Lung Cancer.

Naohisa Chiba, Toshi Menju, Yumeta Shimazu

Pageof 3

Frequent Collaborators

9 joint publications

Hiroshi Date

8 joint publications

Masatsugu Hamaji

7 joint publications

Satona Tanaka

4 joint publications

Yojiro Yutaka